516 related articles for article (PubMed ID: 16313982)
1. Malagashanine potentiates chloroquine antimalarial activity in drug resistant Plasmodium malaria by modifying both its efflux and influx.
Ramanitrahasimbola D; Rasoanaivo P; Ratsimamanga S; Vial H
Mol Biochem Parasitol; 2006 Mar; 146(1):58-67. PubMed ID: 16313982
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo chloroquine-potentiating action of Strychnos myrtoides alkaloids against chloroquine-resistant strains of Plasmodium malaria.
Rasoanaivo P; Ratsimamanga-Urverg S; Milijaona R; Rafatro H; Rakoto-Ratsimamanga A; Galeffi C; Nicoletti M
Planta Med; 1994 Feb; 60(1):13-6. PubMed ID: 8134408
[TBL] [Abstract][Full Text] [Related]
3. Functional characteristics of the malaria parasite's "chloroquine resistance transporter": implications for chemotherapy.
Summers RL; Martin RE
Virulence; 2010; 1(4):304-8. PubMed ID: 21178460
[TBL] [Abstract][Full Text] [Related]
4. Fluoxetine potentiates chloroquine and mefloquine effect on multidrug-resistant Plasmodium falciparum in vitro.
Khairul MF; Min TH; Low JH; Nasriyyah CH; A'shikin AN; Norazmi MN; Ravichandran M; Raju SS
Jpn J Infect Dis; 2006 Oct; 59(5):329-31. PubMed ID: 17060702
[TBL] [Abstract][Full Text] [Related]
5. Roxithromycin potentiates the effects of chloroquine and mefloquine on multidrug-resistant Plasmodium falciparum in vitro.
Min TH; Khairul MF; Low JH; Che Nasriyyah CH; A'shikin AN; Norazmi MN; Ravichandran M; Raju SS
Exp Parasitol; 2007 Apr; 115(4):387-92. PubMed ID: 17118354
[TBL] [Abstract][Full Text] [Related]
6. Glutathione-S-transferases from chloroquine-resistant and -sensitive strains of Plasmodium falciparum: what are their differences?
Rojpibulstit P; Kangsadalampai S; Ratanavalachai T; Denduangboripant J; Chavalitshewinkoon-Petmitr P
Southeast Asian J Trop Med Public Health; 2004 Jun; 35(2):292-9. PubMed ID: 15691127
[TBL] [Abstract][Full Text] [Related]
7. Synergistic interaction of a chloroquine metabolite with chloroquine against drug-resistant malaria parasites.
Kalkanidis M; Klonis N; Tschan S; Deady LW; Tilley L
Biochem Pharmacol; 2004 Apr; 67(7):1347-53. PubMed ID: 15013850
[TBL] [Abstract][Full Text] [Related]
8. Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum.
Meierjohann S; Walter RD; Müller S
Biochem J; 2002 Dec; 368(Pt 3):761-8. PubMed ID: 12225291
[TBL] [Abstract][Full Text] [Related]
9. Uptake of a fluorescently tagged chloroquine analogue is reduced in CQ-resistant compared to CQ-sensitive Plasmodium falciparum parasites.
Reiling SJ; Rohrbach P
Malar J; 2019 Oct; 18(1):342. PubMed ID: 31590674
[TBL] [Abstract][Full Text] [Related]
10. Chloroquine transport in Plasmodium falciparum. 1. Influx and efflux kinetics for live trophozoite parasites using a novel fluorescent chloroquine probe.
Cabrera M; Natarajan J; Paguio MF; Wolf C; Urbach JS; Roepe PD
Biochemistry; 2009 Oct; 48(40):9471-81. PubMed ID: 19728740
[TBL] [Abstract][Full Text] [Related]
11. Flashback to the 1960s: utility of archived sera to explore the origin and evolution of Plasmodium falciparum chloroquine resistance in the Pacific.
Chan CW; Lynch D; Spathis R; Hombhanje FW; Kaneko A; Garruto RM; Lum JK
Acta Trop; 2006 Aug; 99(1):15-22. PubMed ID: 16890903
[TBL] [Abstract][Full Text] [Related]
12. Dual-acting diamine antiplasmodial and chloroquine resistance modulating agents.
Yeh S; Smith PJ; Chibale K
Biochem Pharmacol; 2006 Jul; 72(2):156-65. PubMed ID: 16730664
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of a protein tyrosine kinase activity in Plasmodium falciparum by chloroquine.
Sharma A; Mishra NC
Indian J Biochem Biophys; 1999 Oct; 36(5):299-304. PubMed ID: 10844978
[TBL] [Abstract][Full Text] [Related]
14. Effects of dipyridamole on Plasmodium falciparum-infected erythrocytes.
Akaki M; Nakano Y; Ito Y; Nagayasu E; Aikawa M
Parasitol Res; 2002 Dec; 88(12):1044-50. PubMed ID: 12444453
[TBL] [Abstract][Full Text] [Related]
15. Spinning disk confocal microscopy of live, intraerythrocytic malarial parasites. 2. Altered vacuolar volume regulation in drug resistant malaria.
Gligorijevic B; Bennett T; McAllister R; Urbach JS; Roepe PD
Biochemistry; 2006 Oct; 45(41):12411-23. PubMed ID: 17029397
[TBL] [Abstract][Full Text] [Related]
16. Plasmodium berghei: dehydroepiandrosterone sulfate reverses chloroquino-resistance in experimental malaria infection; correlation with glucose 6-phosphate dehydrogenase and glutathione synthesis pathway.
Safeukui I; Mangou F; Malvy D; Vincendeau P; Mossalayi D; Haumont G; Vatan R; Olliaro P; Millet P
Biochem Pharmacol; 2004 Nov; 68(10):1903-10. PubMed ID: 15476661
[TBL] [Abstract][Full Text] [Related]
17. Reversal activity of the naturally occurring chemosensitizer malagashanine in Plasmodium malaria.
Rafatro H; Ramanitrahasimbola D; Rasoanaivo P; Ratsimamanga-Urverg S; Rakoto-Ratsimamanga A; Frappier F
Biochem Pharmacol; 2000 May; 59(9):1053-61. PubMed ID: 10704934
[TBL] [Abstract][Full Text] [Related]
18. Is PfCRT a channel or a carrier? Two competing models explaining chloroquine resistance in Plasmodium falciparum.
Sanchez CP; Stein WD; Lanzer M
Trends Parasitol; 2007 Jul; 23(7):332-9. PubMed ID: 17493873
[TBL] [Abstract][Full Text] [Related]
19. Current understanding of the molecular basis of chloroquine-resistance in Plasmodium falciparum.
Jiang H; Joy DA; Furuya T; Su XZ
J Postgrad Med; 2006; 52(4):271-6. PubMed ID: 17102545
[TBL] [Abstract][Full Text] [Related]
20. Antiretroviral protease inhibitors potentiate chloroquine antimalarial activity in malaria parasites by regulating intracellular glutathione metabolism.
He Z; Chen L; You J; Qin L; Chen X
Exp Parasitol; 2009 Oct; 123(2):122-7. PubMed ID: 19538959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
